Search Within

Qin Zhou

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (14)
  2. Meeting Abstract (8)
Groups
  1. GSK Faculty (22)
  2. Human Oncology and Pathogenesis Program (22)
  3. Surgery (20)
  4. Department of Pathology and Laboratory Medicine (19)
  5. Biostatistics Service (16)
  6. Department of Medicine (16)

More Groups

People
  1. Alexia Iasonos (13)
  2. Carol Aghajanian (11)
  3. Michael Berger (9)
  4. Britta Weigelt (8)
  5. Marc Ladanyi (7)
  6. Rachel Grisham (7)

More People

Years
  1. 2024 (3)
  2. 2023 (6)
  3. 2021 (1)
  4. 2020 (1)
  5. 2015 (1)
  6. 2014 (1)

More Years

Publications
  1. Journal of Clinical Oncology (5)
  2. Cancer (2)
  3. Clinical Cancer Research (2)
  4. Gynecologic Oncology (2)
  5. Journal of Thoracic Oncology (2)
  6. Laboratory Investigation (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (6)
  2. Elsevier Inc. (4)
  3. American Association for Cancer Research (3)
  4. Nature Publishing Group (3)
  5. Oxford University Press (2)
  6. Wiley Blackwell (2)

More Publishers

Results (22)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characteristics and outcome of AKT1(E17K)-mutant breast cancer defined through AACR Project GENIE, a clinicogenomic registry
    Journal Article

    Smyth, L. M.; Zhou, Q.; Nguyen, B.; Yu, C.; Lepisto, E. M.; Arnedos, M.; Hasset, M. J.; Lenoue-Newton, M. L.; Blauvelt, N.; Dogan, S.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • Molecular subtypes of uterine leiomyosarcoma and correlation with clinical outcome
    Journal Article

    Barlin, J. N.; Zhou, Q. C.; Leitao, M. M.; Bisogna, M.; Olvera, N.; Shih, K. K.; Jacobsen, A.; Schultz, N.; Tap, W. D.; Hensley, M. L.; more...
    NeoPlasia (2015)

    Fulltext@MSK | Save
  • The performance of BRCA1 immunohistochemistry for detecting germline, somatic, and epigenetic BRCA1 loss in high-grade serous ovarian cancer
    Journal Article

    Meisel, J. L.; Hyman, D. M.; Garg, K.; Zhou, Q.; Dao, F.; Bisogna, M.; Gao, J.; Schultz, N. D.; Grisham, R. N.; Phillips, M.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • BRAF Mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer
    Journal Article

    Grisham, R. N.; Iyer, G.; Garg, K.; DeLair, D.; Hyman, D. M.; Zhou, Q.; Iasonos, A.; Berger, M. F.; Dao, F.; Spriggs, D. R.; more...
    Cancer (2013)

    Fulltext@MSK | Save
  • A comprehensive analysis of BRAF and KRAS mutation status in low-grade serous (LGS) and serous borderline (SB) ovarian cancer (OC)
    Meeting Abstract

    Grisham, R. N.; Garg, K.; Zhou, Q.; Iasonos, A.; Berger, M. F.; Dao, F.; Hyman, D. M.; Levine, D. A.; Solit, D. B.; Aghajanian, C.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Association of NF2 loss and MTOR pathway activation in pleural mesothelioma: Comprehensive genetic analysis of NF2 and immunohistochemistry in 13 cell lines and 53 tumors
    Meeting Abstract

    Brevet, M.; Bott, M.; Zhou, Q.; Rusch, V.; Ladanyi, M.
    Modern Pathology (2011)

    Fulltext@MSK | Save
  • Association of NF2 loss and MTOR pathway activation in pleural mesothelioma: Comprehensive genetic analysis of NF2 and immunohistochemistry in 13 cell lines and 53 tumors
    Meeting Abstract

    Brevet, M.; Bott, M.; Zhou, Q.; Rusch, V.; Ladanyi, M.
    Laboratory Investigation (2011)

    Fulltext@MSK | Save
  • The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma
    Journal Article

    Bott, M.; Brevet, M.; Taylor, B. S.; Shimizu, S.; Ito, T.; Wang, L.; Creaney, J.; Lake, R. A.; Zakowski, M. F.; Reva, B.; more...
    Nature Genetics (2011)

    Fulltext@MSK | Save
  • Coactivation of receptor tyrosine kinases in malignant mesothelioma as a rationale for combination targeted therapy
    Journal Article

    Brevet, M.; Shimizu, S.; Bott, M. J.; Shukla, N.; Zhou, Q.; Olshen, A. B.; Rusch, V.; Ladanyi, M.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • Use of integrated genomic analysis to evaluate BRCA-associated protein 1 (BAP1) as a mutated gene in malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Bott, M. J.; Brevet, M.; Taylor, B. S.; Shimizu, S.; Ito, T.; Zhou, Q.; Olshen, A.; Zakowski, M. F.; Rusch, V. W.; Ladanyi, M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save